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Introduction: Pyomyositis, though classically considered a tropical disease, has a variable geographic prevalence.
Among the predisposing risk factors, immunodeficiency plays an important role. Pyomyositis has a tendency to
mimic more commonly considered diseases, and a lack of familiarity with it is a cause of delayed diagnosis.
Case presentation: A 53-year-old South Asian man with newly diagnosed type 2 diabetes mellitus was referred to
our medical unit in an advanced stage of the disease, which was complicated by sepsis and acute kidney injury.
Failure of the referring unit to provide prompt treatment, as well as their delay in coming to a diagnosis, led to the
patient’s complicated state. Antibiotic therapy was initiated, and clinical stabilization was achieved with supportive
measures. Following the patient’s recovery from sepsis, his persistent leukopenia and anemia was suggestive of an
underlying immunodeficiency, and a subsequent bone marrow biopsy revealed acute myeloid leukemia, M2 variant.
Multi-disciplinary care was initiated by the medical, surgical and oncological teams.
Conclusion: Awareness of tropical pyomyositis is lacking. Common predisposing behaviors and conditions should
always be sought and investigated. Immunosuppressive state is an important predisposing factor in the
pathogenesis of pyomyositis. Early antibiotic treatment is pivotal in management, and surgical intervention, when
relevant, should not be delayed. Identifying one cause should not halt the search for others, as pyomyositis may
herald underlying sinister diseases.
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Pyomyositis is classically considered a disease of the tro-
pics and has been known to make up 4% of all admis-
sions in certain African nations [1]. Immunity plays a
pivotal role, as it has been observed to be commoner in
patients in compromised states, whether it be secondary
to HIV or to non-infective states predisposing the pa-
tient to immune system impairment (for example, dia-
betes mellitus, rheumatologic diseases and malignancy).
This phenomenon has thus caused an increased preva-
lence of pyomyositis, even in temperate countries [2]. In
addition to impaired immunity, other risk factors include
intravenous drug use and trauma that may be considered
trivial [3]. Characteristically, the predominant causative
organism is Staphylococcus aureus, which may even be
methicillin-resistant [4,5]. However, in patients in im-
munocompromised states, organisms may show a varying* Correspondence: rayno.navinan@gmail.com
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unless otherwise stated.pattern, such as Gram-negative bacteria; Streptococcus
groups B, C and G; Mycobacterium avium [4]; and many
others. Pyomyositis mainly affects the major muscle
groups of the limb girdles, especially the quadriceps, caus-
ing suppuration leading to abscesses [3,6]. The diagnosis
may be difficult, as it may mimic more commonly consid-
ered diseases of the tropics, such as cellulitis, dengue,
leptospirosis, viral fever and osteomyelitis [7]. This may be
attributed to lack of familiarity or the absence of specific
signs [3]. In this report, we present a unique case of trop-
ical pyomyositis that heralded an underlying silent and
sinister etiology masked by the presence of obvious risk
factors requiring management with a multi-disciplinary
approach.
Case presentation
A 53-year-old South Asian man recently diagnosed with
type 2 diabetes mellitus who had been receiving treat-
ment for 2 months with oral hypoglycemic drugs pre-
sented to our hospital with slow, insidious, progressivel. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 T2-weighted magnetic resonance image of the left
thigh shows pyomyositis. T2-weighted magnetic resonance image
of the left thigh taken in the sagittal plane reveals a multi-loculated
mass in the medial aspect that demonstrates high signal intensity.
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otherwise healthy and denied any high-risk behavior,
smoking or alcohol consumption in the past. His presen-
tation to us was delayed, as he initially failed to seek at-
tention with worsening symptoms. Upon his initial
admission to the hospital for investigation and manage-
ment, despite persistent fever, the investigating unit
failed to suspect pyomyositis. They treated the patient
with intravenous cloxacillin 1g every 6 hours, suspecting
cellulitis. With the development of acute confusion, the
patient was presented to our medical unit for further
management. The patient had no preceding history of
trauma. The patient’s examination revealed that he was
febrile, had a high body temperature (39°C) and was
confused (Glasgow Coma Scale score of 11 out of 15)
with acidotic breathing. His abdominal, respiratory and
remaining neurologic system examination results were
normal. Despite his condition, the patient’s blood pres-
sure remained within normal parameters, though tachy-
cardia was noted. His left thigh was observed to be
disproportionately swollen, warm and tense to touch.
Whole-blood analysis revealed a grossly elevated white
blood cell count of 34×109/L (normal range, 4×109/L to
11×109/L), which was predominantly neutrophilic (86%).
He had a low hemoglobin concentration of 6.8g/dl (normal
range, 11g/dl to 18g/dl) and a platelet count of 158×109/L
(normal range, 150×109/L to 450×109/L). His C-reactive
protein concentration was elevated at 258mg/L (normal
range, <8mg/L). His blood culture tests were negative re-
peatedly. His serum creatinine level was elevated at
140μmol/L (normal range, 60μmol/L to 120μmol/L) and
rising, with the highest value recorded at 195μmol/L. Des-
pite his rising creatinine level, his electrolytes remained
normal. His coagulation profile was deranged, with an ele-
vated international normalized ratio of 2.59 and an acti-
vated thromboplastin time of 41 seconds (normal range,
24 to 36 seconds). His serum ammonia level was elevated
at 69μmol/L (normal range, 26μmol/L to 47μmol/L), and
he had a high serum lactate dehydrogenase value of
531IU/L (normal range, 230IU/L to 460IU/L). His total
bilirubin was elevated at 93μmol/L (normal range, 5μmol/
L to 21μmol/L) and showed a predominant indirect frac-
tion. His alkaline phosphatase concentration was margin-
ally elevated at 345IU/L (normal range, 98IU/L to 279IU/
L), but his aspartate and alanine transaminase values were
normal at 32IU/L (normal range, <34IU/L) and 38IU/L
(normal range, 11IU/L to 50IU/L), respectively. His total
proteins were found to be mildly reduced at 5.1g/dl (nor-
mal range, 6.4g/dl to 8.4g/dl). Though marginally low, his
albumin level remained predominant, with a value of 2.7g/
dl (normal range, 3.7g/dl to 5.4g/dl). His preliminary fast-
ing blood sugar values were found to be elevated at
215mg/dl (normal range, less than 126mg/dl), reflecting
poor control.His blood picture revealed normocytic normochromic
red cells, polychromatic cells, red cell fragments with
toxic neutrophils and mild thrombocytopenia. These fea-
tures were compatible with hemolysis secondary to sep-
sis. The result of retroviral screening was negative.
Ultrasound imaging of the abdomen revealed a slightly
hypoechoic, mildly enlarged liver with normal ducts and
splenomegaly of 13.36cm. Magnetic resonance imaging
(MRI) of the patient’s left thigh and pelvis revealed a
multi-loculated mass, most likely an abscess, which mea-
sured 20cm in length and 8mm in its widest diameter.
The mass demonstrated high signal intensity in the med-
ial aspect of the thigh on T2-weighted images (Figure 1),
confirming our clinical suspicion of pyomyositis. Cultures
of the drained pus were found to be sterile. However, a
muscle biopsy and culture was positive for a non-lactose
fermenting coliform organism (sensitive to cefoperazone
and sulbactam, netilmicin and ciprofloxacin; inter-
mediate sensitivity to ticarcillin-clavulanate; and resistance
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gentamicin). A coagulase-negative, methicillin-resistant
Staphylococcus aureus isolate was also detected, but
contamination was considered likely.
Thus, the patient was initiated on intravenous cefoper-
azone and sulbactam 1g every 12 hours for 2 weeks. In
view of his rising serum creatinine level, we opted for
one cycle of hemodialysis with strict fluid management,
which resulted in resolution of his acute kidney injury.
He was transfused with packed red blood cells to achieve
and maintain his hemoglobin levels. He demonstrated
dramatic clinical improvement, with normalization of
consciousness and stabilization of his whole-blood count
values to normal. After 8 days of treatment and achieve-
ment of stabilization, the significant amount of pus ne-
cessitated surgical intervention. Thus, a surgical consult
was sought. The patient’s loculated pus was drained,
which was found to be sterile when cultured. Tight gly-
cemic control was achieved with subcutaneous adminis-
tration of soluble insulin, and the patient’s capillary
blood sugar values were maintained below 200mg/dl.
However, following drainage and treatment with intraven-
ous antibiotics, the development and persistence of
leukopenia (2.51×109/L (normal range, 4×109/L to
11×109/L)) with lymphocytic predominance of 81%
(normal range, 20% to 40%), coupled with normocytic
normochromic anemia in whole-blood analysis despite
clinical improvement, prompted further investigation.
On the basis of suspecting an underlying leukemia, a
bone marrow biopsy was done and revealed a markedly
hypercellular marrow with 22% abnormal blasts and
reactive granulocytic hyperplasia. The flow cytometric
and morphologic findings were compatible with acute
myeloid leukemia (AML), M2 variant (AML-M2). The pa-
tient was then referred for further oncologic management.
Discussion
South Asian countries such as India and Sri Lanka are
classified as tropical; however, only a few sporadic cases
and case series of tropical pyomyositis have been re-
ported [8-10]. This may be due to an overall lack of
awareness and underreporting rather than the lack of
prevalence. In this report, we present a case of a patient
with pyomyositis who demonstrated classic etiologic
predisposing factors: underlying subclinical AML with
type 2 diabetes mellitus that progressed to systemic sepsis
with acute kidney injury. The unique presenting manifest-
ation of AML in our patient was pyomyositis due to sec-
ondary infection.
Immunocompromised states should always be excluded
when pyomyositis is suspected [3]. Although the tropical
environment by itself is a risk factor, South Asians also
have a high incidence of type 2 diabetes mellitus, a well-
known cause of impaired immunity and a risk factor forpyomyositis. Our patient had type 2 diabetes mellitus.
Though it was a recent diagnosis, it would have been a si-
lent yet established predisposing etiologic factor. What
made the case unique, however, was his dual pathology of
AML-M2, which further enhanced the effect of his im-
munocompromised state. This might explain the large
amount of pus with its complexity and loculation, and
even the late stage of presentation. This case reemphasizes
the need to carry out all relevant investigations to exclude
underlying causes of immunocompromise. The identifica-
tion of one predisposing cause should not stop the etio-
logic search for others, because underlying subclinical
sinister causes may be discovered that require urgent
intervention. The importance of immunocompetence and
its impact on the presentation of pyomyositis is demon-
strated by our present case. Hematologic malignancies are
known to be associated with pyomyositis. Falagas and col-
leagues [11], in their comprehensive review, detailed the
various malignancies that have been reported thus far.
These include AML, acute lymphoblastic leukemia, acute
myelomonocytic leukemia, chronic myeloid leukemia,
chronic lymphocytic leukemia, myeloproliferative disease,
myelodysplastic syndrome, plasma cell leukemia, myelo-
monocytic leukemia, multiple myeloma, non-Hodgkin’s
and Hodgkin’s lymphoma, diffuse large B-cell lymphoma
and lymphoblastic lymphoma. Though Staphylococcus
aureus predominated in most of these documented cases,
a variety of atypical organisms were also noted.
Treatment of pyomyositis depends on staging, which
is categorized into three stages [3,6]. Stage 1 (invasive
stage) is early and has relatively mild signs and symp-
toms, with minimal systemic signs and little or no pus.
Stage 2 (suppurative stage) is an advanced stage in which
most present, and the symptoms are severe due to pres-
ence of pus. Stage 3 (late stage) is the final stage, where
there is systemic toxicity, dissemination of infection and
organ dysfunction. Only the preliminary stage may be
managed medically; the latter two require a combination
of medical management with surgical intervention [3,6].
The case of our patient demonstrates the typical insidi-
ous pattern that progresses to purulent collections, also
described by Patel and colleagues [12]. Though our pa-
tient was in the latter part of stage 2 when he sought
treatment initially, his condition deteriorated quickly to
stage 3. He was referred to us in a state of sepsis compli-
cated by confusion and acute kidney injury and without
a definitive diagnosis. After we made a confident diagno-
sis based on the patient’s history and physical signs and
affirmed by MRI, the patient was hemodialyzed and his
septic state was stabilized, and he was referred back for
drainage of the loculated pus collection with follow-up
oncologic intervention.
Tropical pyomyositis can be a disease with multiple
clinical complexities. The presence of it should alert the
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viduals to such a disease. Tropical pyomyositis may be
the first heralding feature of yet to be diagnosed clinical
conditions that may be more sinister than the disease
process itself.
Conclusion
Awareness of tropical pyomyositis is lacking among the
medical fraternity, and a high degree of clinical suspicion
should facilitate early diagnosis. Though antibiotic treat-
ment is pivotal in the management of pyomyositis and
needs to be initiated early surgical intervention, when
deemed clinically relevant, should be sought. Immuno-
suppression plays a key role in the pathogenesis of pyo-
myositis, and a full spectrum of investigations to exclude
common predisposing conditions should always be car-
ried out. The identification of one cause should not halt
the search for others, as rarely tropical pyomyositis may
herald sinister diseases that are subclinical. Thus, typical
risk factors and behaviors should be sought for and in-
vestigated, and, through the course of the illness, com-
plications should be anticipated and managed promptly.
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